Form 4 for PCSA Processa Pharmaceuticals, Inc.
Accepted 2021-10-08 00:00:00 ET · period of report 2021-10-06 · accession 0001567619-21-018171 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-08 | 2021-10-06 | PCSA | Floyd Robert Michael | COO | F - Tax | $0.00 | -4,663 | 9,387 | -33% | $0 | |
| 2021-10-08 | 2021-10-06 | PCSA | Floyd Robert Michael | COO | M - OptEx | — | +12.5K | 14.5K | +625% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-06 | F | D | 4,663 | $0.00 | 9,387 | D | — | — | |
| 2 | Common | Common Stock | 2021-10-06 | M | A | 12,500 | — | 14,500 | D | — | — | (F1) Vesting of restricted stock. |